Williams under scrutiny for admission about weight-loss supplements usage

In a surprising turn of events, tennis pro Serena Williams has partnered with GLP-1 medicine company Ro, announcing her use of the drug in a public campaign. However, the move has sparked criticism and disappointment among fans and critics alike.

The controversy stems from Williams' statement that the drug was what her body "needed." Critics label this statement as wrong and dangerous, while some find it problematic. The criticism suggests that Williams' endorsement could negatively influence body confidence and recovery expectations among young athletes.

One critic claims that the endorsement sends a terrible message to young female athletes who look up to Williams. Another argues that the medicine should not be called healthcare, while some commenters express disappointment because Williams is using medication for body confidence.

A social media user commented that the video made them sad and disappointed, while a critic states that it is disturbing to see such a message coming from a former elite athlete like Williams. The criticism focuses on the potential impact of Williams' endorsement on young female athletes.

Despite the criticism, no public response has been made by Williams regarding the controversy. It is worth noting that Williams is 43 years old and turned to the drug after having two children.

The drug Williams is using is GLP-1 medicine, a weekly drug that helps with weight loss and blood sugar control. Critics argue that Williams' statement about the medicine being "needed" could undermine the message of taking time to recover and get back in shape.

Interestingly, based on search results, there is no information available about anyone publicly opposing Williams regarding her involvement in the campaign. As the controversy continues to unfold, it remains to be seen how Williams will respond to the criticism and whether her endorsement will have a lasting impact on young athletes.